Bharat Biotech fixes price of Covaxin at Rs 600 per dose for states, Rs 1,200 for private hospitals

The Hyderabad-based company is currently supplying the vaccine to the Central Government at Rs 150 per dosage and the government on its part is distributing it free of cost

Press Trust of India April 24, 2021 23:00:48 IST
Bharat Biotech fixes price of Covaxin at Rs 600 per dose for states, Rs 1,200 for private hospitals

Representational image. PTI

New Delhi: Bharat Biotechon Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage.

The Hyderabad-based vaccine major also said that it would provide the vaccine to private hospitals at Rs 1,200 per dosage.

In a statement, Bharat Biotech chairman and managing director Krishna M Ella said the company is supplying the vaccine to the Central Government at Rs 150 per dosage and the government on its part is distributing it free of cost.

"We would like to state that more than 50 percent of our capacities have been reserved for Central Government supplies," Ella said.

Recovering the cost is essential in the journey of innovation towards other vaccines such as intranasal COVID-19 , Chikungunya, Zika, Cholera and others, he added.

Updated Date:

also read

AIIMS Delhi begins screening children for Covaxin trials; 525 volunteers to be roped in
India

AIIMS Delhi begins screening children for Covaxin trials; 525 volunteers to be roped in

AIIMS Patna has already started clinical trials to gauge whether the Bharat Biotech-developed COVID-19 vaccine is suitable for children

Bharat Biotech's Covaxin trials on children between 2-18 years of age amounts to homicide: Plea in Delhi HC
India

Bharat Biotech's Covaxin trials on children between 2-18 years of age amounts to homicide: Plea in Delhi HC

Petitioner Sanjeev Kumar said the children could suffer adverse health or mental effects due to the vaccine testing.

Delta variant of COVID-19 can infect despite Covishield, Covaxin doses, claims preliminary AIIMS study
India

Delta variant of COVID-19 can infect despite Covishield, Covaxin doses, claims preliminary AIIMS study

The study included 63 people who got breakthrough infections; of which 36 patients received two doses, while 27 had received one dose of vaccine